Paul Marik

Paul Marik

Home
Notes
Cancer Playbook: Smarter Stra…
Metabolic Healing Playbook
Archive
About
Why Randomized Controlled Trials Are Poorly Suited to Testing Repurposed Drugs and Nutraceuticals in Cancer
The Case for Well-Conducted Observational Studies
 • Cancer & Metabolic Healing
Luteolin: A versatile anticancer agent (and Genistein).
Luteolin has one of the broadest anticancer profiles among naturally occurring flavonoids.
 • Cancer & Metabolic Healing
To Cycle or Not to Cycle: Rethinking Doxycycline and Mebendazole
A reevaluation of Cycling Doxycycline and Mebendazole
 • Cancer & Metabolic Healing
A Patient Story: From Confusion to Clarity
A Result Worth Fighting For
 • Cancer & Metabolic Healing
The Ivermectin and Mebendazole Dosing Question: Patient and Provider Responses
The Dose Makes The Poison
 • Cancer & Metabolic Healing
The Ivermectin and Mebendazole Dosing Question: What Is the Optimal Dose for Cancer?
This is one of the commonest questions I get asked.
 • Cancer & Metabolic Healing
Integration of Metronomic chemotherapy with repurposed drugs
An Integrative Oncologic Strategy Focused on Angiogenesis, Metabolism, and Immune Modulation
 • Cancer & Metabolic Healing
THE CANCER & METABOLIC LIBRARY
Provisional Table of Contents
 • Cancer & Metabolic Healing
Overview of Chemotherapy and Metronomic Dosing
Chemotherapy drugs work primarily by targeting rapidly dividing cells, a hallmark of cancer.
 • Cancer & Metabolic Healing
Doxycycline
The anti-cancer antibiotic
 • Cancer & Metabolic Healing
Sulforaphane
The anti-cancer compound in Broccoli
 • Cancer & Metabolic Healing
Bridging the Gap: Can Repurposed Drugs and Nutraceuticals Bridge Periods of Conventional Therapy Interruption?
Interruptions in conventional cancer therapy are common.
 • Cancer & Metabolic Healing
© 2026 Paul Marik · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture